Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals.

On October 16, a biotechnology company in Massachusetts in the U.S. named Wave Life Sciences made headlines for becoming the ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Verve Therapeutics (VERV – Research Report) and decreased the ...

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of ...

Spanish biotech Integra Therapeutics has upped its arsenal of gene editing tools by licensing Caszyme’s Cas12I nucleases, the ...

MercadoLibre has a history of rewarding investors who buy on dips. Wood is a fan of the potential for gene editing as a way ...

Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...

Editas Medicine announced proof-of-concept data for a gene-editing approach for sickle cell disease that doesn't need a stem ...